TherapeuticsMD, Inc. (TXMD)
Q3 2019 Earnings Conference Call
November 06, 2019 04:30 PM ET
Company Participants
Nichol Ochsner - Vice President, Investor Relations
Robert Finizio - Chief Executive Officer
Dan Cartwright - Chief Financial Officer
Dawn Halkuff - Chief Commercial Officer
Conference Call Participants
Annabel Samimy - Stifel
Sudan Naveen Loganathan - Cantor Fitzgerald
Ekaterina Knyazkova - JPMorgan
Douglas Tsao - HCW
Presentation
Operator
Good afternoon, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD Third Quarter 2019 Financial Results Conference Call. Following prepared remarks from the company, we will open the call